Cambridge Investment Research Advisors, Inc. Oramed Pharmaceuticals Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$1.93 - $13.1 $11,942 - $81,062
6,188 Added 50.79%
18,372 $40,000
Q4 2022

Feb 08, 2023
SELL
$5.88 - $12.03 $11,760 - $24,060
-2,000 Reduced 14.1%
12,184 $147,000
Q3 2022

Oct 17, 2022
BUY
$4.6 - $9.91 $13,799 - $29,730
3,000 Added 26.82%
14,184 $0
Q2 2022

Jul 13, 2022
BUY
$3.72 - $9.0 $41,604 - $100,656
11,184 New
11,184 $51,000

Others Institutions Holding ORMP

# of Institutions
63
Shares Held
7.4M
Call Options Held
4K
Put Options Held
2.1K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email